Related Experiment Video
Updated: Jun 15, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
Machine Learning to Predict Early Death Despite Pancreaticoduodenectomy
Kaleem S Ahmed1, Clayton T Marcinak1, Sheriff M Issaka1
1Division of Surgical Oncology, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Machine learning models can predict futile pancreaticoduodenectomy (PD) in pancreatic ductal adenocarcinoma (PDAC) patients with moderate accuracy. This aids in shared decision-making for optimized patient care.
Area of Science:
- Oncology
- Machine Learning
- Surgical Outcomes
Background:
- Pancreaticoduodenectomy (PD) for right-sided pancreatic ductal adenocarcinoma (PDAC) has a 25% 1-year mortality rate.
- A significant portion of patients experience morbidity without survival benefits from PD compared to non-surgical options.
Purpose of the Study:
- To compare the accuracy of machine learning models against traditional regression models in predicting futile surgery for PDAC patients.
- To identify key preoperative factors associated with futile PD.
Main Methods:
- Analysis of National Cancer Database data (2004-2020) for PDAC patients undergoing PD.
- Definition of futile PD as death within 12 months of cancer diagnosis.
- Training and testing of logistic regression, multilayer perceptron, decision tree, random forest, and gradient boosting models using 16 preoperative variables.
Main Results:
- Out of 66,331 patients, 25.3% met criteria for futile surgery.
- Gradient boosting model achieved the highest accuracy (AUC 0.689), outperforming logistic regression, random forest, and decision tree.
- Predictors of futile PD included advanced age, larger tumor size, and poor differentiation; neoadjuvant therapy reduced futility risk.
Conclusions:
- Machine learning models demonstrate moderate accuracy in predicting futile PD for PDAC patients.
- Findings support improved shared decision-making and optimized care strategies for PDAC.
- Further research with more granular data is warranted.
More Related Videos
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018